肺功能的系统性标记物和1秒内强迫呼气体积在不同队列中下降
Debby Ngo1,2, Katherine A Pratte3, Claudia Flexeder4,5,6
1Cardiovascular Research Institute.
Annals of the American Thoracic Society
|June 23, 2023
概括
这项研究确定了与不同种群的肺功能和衰退相关的新型蛋白质生物标志物. 这些发现可能有助于风险分层和慢性阻塞性肺病 (COPD) 治疗的发展.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 肺部医学 肺部医学
- 生物标志物发现发现
背景情况:
- 慢性阻塞性肺病 (COPD) 的特点是气道阻塞和加速的肺功能下降.
- 与COPD相关的系统性蛋白质生物标志物尚未完全理解.
- 识别新生物标志物对于COPD风险分层和治疗目标至关重要.
研究的目的:
- 在多样化的人群中识别与肺功能受损相关的蛋白质和途径.
- 调查蛋白质水平与肺功能下降的速度之间的关联.
主要方法:
- 分析了六项队列研究中6,722名参与者的基于Aptamer的蛋白质和螺旋测量数据.
- 线性回归模型检查了蛋白质与基线强迫呼吸量在1秒 (FEV1) 和FEV1/强迫生命能力 (FVC) 的相关性.
- 线性混合效应模型评估了蛋白质与FEV1随时间的下降率的关联.
主要成果:
- 在发现分析中,254种蛋白与FEV1相关,其中80种被验证.
- 经过验证的新型蛋白质包括卡利斯塔丁,生长分化因子2和瘤亡因子类弱诱导亡.
- 15种蛋白与FEV1的下降有关,包括elafin和粘素相关的TFF2.2.
结论:
- 新型蛋白质生物标志物和与肺功能和衰退相关的途径在多样化的人口中被确定并验证.
- 已识别的蛋白质,如卡利斯塔丁,埃拉芬和TFF2,可能作为COPD风险分层的潜在标志物.
- 这些发现突出了COPD异常的细胞外矩阵重塑,免疫反应,血管生成和凝血途径.
相关概念视频
Pulmonary Function Tests
379
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
379
COPD: Pathogenesis and Clinical Features
365
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
365
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Lung Capacity
51.0K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
51.0K


